Form 4: CEO Sells RPID Shares for Tax Obligations

Rapid Micro Biosystems CEO Robert G. Spignesi Jr. sold 12,840 shares of Class A Common Stock to cover tax obligations related to restricted stock unit vesting.

Summary

• Robert G. Spignesi Jr., President and CEO, and a Director of Rapid Micro Biosystems, Inc. (RPID), reported a transaction.
• On February 9, 2026, Spignesi disposed of 12,840 shares of Class A Common Stock at a price of $3.7827 per share.
• This sale was automatic and intended to cover tax obligations associated with the vesting of restricted stock units.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.
• Following this transaction, Spignesi beneficially owns 962,097 shares of Class A Common Stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was non-discretionary and solely for tax purposes related to equity compensation, not a reflection of management's sentiment towards the company's future.

Future Outlook

No forward-looking statements or guidance are provided in this filing, as it reports a past insider transaction.

Management Comments

• The sale of stock represents the automatic sale to cover associated tax obligations with the vesting of restricted stock units.

Industry Context

StockSavvy.ai notes that 'sell-to-cover' transactions, where executives sell shares to satisfy tax liabilities upon the vesting of equity awards, are a routine and common practice across industries. Such transactions are generally not indicative of a change in management's outlook on the company's future prospects.

Comparison to Industry Standards

• The 'sell-to-cover' transaction by CEO Robert G. Spignesi Jr. aligns with standard executive compensation and tax planning practices observed across various industries, including biotechnology and medical device sectors.
• This type of non-discretionary sale is a common mechanism for executives to manage tax liabilities arising from equity awards, similar to practices at companies like Thermo Fisher Scientific or Danaher Corporation, which also utilize equity compensation.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary sale for tax purposes, not a signal of reduced confidence by the CEO.

Key Dates

Recommendation

The transaction represents a routine 'sell-to-cover' event for tax obligations related to restricted stock unit vesting, not a discretionary sale indicating a change in management's confidence. Therefore, it does not provide new information to alter an existing investment thesis.

Keywords

Rapid Micro Biosystems, RPID, Robert G. Spignesi Jr., Form 4, Insider Trading, Stock Sale, Restricted Stock Units, Tax Obligations, CEO, Corporate Governance